Resources 
and support

AQUIPTA 60 mg atogepant tablets pack

Resources to support you with your migraine management

Aquipta Treatment Companion

AQUIPTA
Treatment Companion

To support migraine management, includes a migraine diary, healthy habits, and tips for taking AQUIPTA.

Download now
Migraine Foundation Aotearoa New Zealand

Migraine Foundation Aotearoa New Zealand

A collective voice for people in New Zealand living with this invisible and disabling condition, providing a wealth of information and support.

Visit now
Healthify He Puna Waiora

Healthify
 He Puna Waiora

Information and resources to help you manage your migraines.

 

Visit now

For more information about AQUIPTA

  • Speak with your healthcare professional
  • Review the AQUIPTA Consumer Medicine Information, available here 
  • Contact the AbbVie Medical Information team at medinfoanz@abbvie.com or freephone 0800 900 030
decorative

Your questions answered

AQUIPTA is a privately-funded prescription medicine used to prevent migraine in adults who have at least 4 migraine days per month.1

Your body naturally produces a protein called calcitonin gene-related peptide, or CGRP, which is believed to play an important role in migraine attacks. When CGRP levels rise, they can contribute to the pain and inflammation associated with migraine. AQUIPTA works by blocking CGRP receptors, helping to prevent migraine attacks before they happen.1–4

If you think that you have taken too much AQUIPTA, you may need urgent medical attention. You should immediately phone the National Poisons Centre (by calling 0800 POISON or 0800 764 766), contact your doctor, or go to the Emergency Department at your nearest hospital. You should do this even if there are no signs of discomfort or poisoning.1

A missed dose should be taken straight away. If it is almost time for your next dose, skip the dose you missed and take your next dose when you are meant to. Do not take a double dose to make up for the dose you missed.1

Do not stop using AQUIPTA without talking to your doctor first. Your migraine symptoms may return if you stop the treatment.1

Your healthcare professional is best placed to advise you based on your individual situation.

Common side effects include decreased appetite, nausea, constipation, drowsiness (sleepiness) and tiredness. Tell your healthcare professional if you notice any of these side effects or if you feel unwell while taking AQUIPTA.1,5

These are not all the possible side effects of AQUIPTA. For the full list of side effects and restrictions with AQUIPTA, see the AQUIPTA Consumer Medicine Information. If you have any questions or concerns about AQUIPTA, speak to your healthcare professional.

Speak with your healthcare professional to see if AQUIPTA is right for you. AQUIPTA is a prescription medicine that can be prescribed by a GP,  specialist, and some nurse and pharmacist prescribers. It is available through select AQUIPTA partner pharmacies, with delivery available anywhere in New Zealand. Learn more here.

Migraine Foundation Aotearoa New Zealand provides a collective voice for people in New Zealand living with this invisible and disabling condition. You can access their website here.

Abbreviation: CGRP, calcitonin gene-related peptide.

References: 1. AQUIPTA® (atogepant) Consumer Medicine Information. 2. Russo AF. Annu Rev Pharmacol Toxicol 2015;55:533–552. 3. Edvinsson L et al. Nat Rev Neurol 2018;14(6):338–350. 4. Edvinsson L. Headache 2017;57(suppl 2):47–55. 5. AQUIPTA® (atogepant) Data Sheet.

NZ-AQP-240021. BG6642. AQU-006007-00. August 2026..